MedPath

Home Study of Subjects Who Have Completed a Previous Continuous Negative External Pressure (cNEP) Clinical Trial

Not Applicable
Withdrawn
Conditions
Obstructive Sleep Apnea
Interventions
Device: continuous negative external pressure
Registration Number
NCT03108417
Lead Sponsor
Sommetrics, Inc.
Brief Summary

This study is designed to determine whether subjects who were responders to cNEP during an overnight sleep lab titration in a previous clinical trial, Study SOM-012, will maintain a response throughout the night for up to two weeks in a home setting. It will also be determined whether two weeks of home use of cNEP is associated with any adverse events.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • must have completed study SOM-012 and been categorized as a "responder"
  • the subject agrees to participation by signing an informed consent statement
Exclusion Criteria
  • medical or social circumstances have changed since participation in SOM-012 such that continued use of cNEP may provide questionable benefit or associated with increased risk

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
cNEPcontinuous negative external pressurecontinuous negative external pressure will be used nightly by all participants
Primary Outcome Measures
NameTimeMethod
Reduction in baseline apnea hypopnea index from baselineEnd of Week 2 of home use

Reduction in apnea hypopnea index (AHI) from the baseline value of \>50% and also \<15/hr

Secondary Outcome Measures
NameTimeMethod
Collection of adverse eventstwo week study period

Collection of adverse events

Apnea hypopnea index, as measured by home sleep testingtwo weeks

Comparison of AHI from home sleep testing in this study to those of the polysomnogram (PSG) in SOM-012

Trial Locations

Locations (1)

California Center for Sleep Disorders

🇺🇸

Alameda, California, United States

© Copyright 2025. All Rights Reserved by MedPath